Cannabis producer Canopy Growth Corporation (NASDAQ: CGC) reported a wider net loss for the third quarter of 2023, hurt by a 28%
Infographic: Highlights of Canopy Growth’s (CGC) Q3 2023 earnings
Categories
Marijuana stocks
Infographic: Highlights of Canopy Growth’s (CGC) Q2 2023 earnings
Cannabis producer Canopy Growth Corporation (NASDAQ: CGC) reported a wider net loss for the second quarter of 2023, hurt by a 10%
TLRY Earnings: Highlights of Tilray’s Q1 2023 financial results
Cannabis company Tilray (NASDAQ: TLRY) has announced financial results for the first quarter of 2023, reporting a wider net loss and a
Canopy Growth Corporation (CGC) Q4 2021 Earnings Call Transcript
Canopy Growth Corporation (NASDA: CGC) Q4 2021 earnings call dated June 01, 2021 Company Participants: Judy Hong -- Vice President, Investor Relations and Competitive Intelligence
Organigram Holdings Inc.(OGI) Q2 2021 Earnings Call Transcript
Organigram Holdings Inc. (NASDAQ: OGI) Q2 2021 earnings call dated Apr. 13, 2021. Corporate Participants: Amy Schwalm -- Vice President, Investor Relations
Canopy Growth Corporation (CGC) Q3 Earnings: Key financials and quarterly highlights
Canopy Growth Corporation (NYSE: CGC) reported Third quarter 2021 earnings results today. Net revenues increased 23% year-over-year to CAD $153 million. Net loss
Cronos Group Inc. (NASDAQ: CRON) Q1 2020 Earnings Call Transcript
Cronos Group Inc. (CRON) Q1 2020 earnings call dated May 08, 2020 Corporate Participants: Shayne Laidlaw -- Investor Relations Mike Gorenstein -- Chairman, President and Chief
Village Farms International Inc. (NASDAQ:VFF) Q4 2019 Earnings Call Transcript
Village Farms International Inc. (NASDAQ: VFF) Q4 2019 Earnings Conference Call Mar. 31, 2020 Corporate Participants: Michael A. DeGiglio -- President & Chief Executive Officer
HEXO Corp. (NYSE: HEXO) Q2 2020 Earnings Call Transcript
HEXO Corp. (NYSE: HEXO) Q2 2020 Earnings Conference Call Mar. 30, 2020 Corporate Participants: Jennifer Smith -- Director, Investor Relations Sebastien St-Louis -- Co-Founder and Chief Executive
Cronos Group Inc. (NASDAQ: CRON) Q4 2019 Earnings Call Transcript
Cronos Group Inc. (NASDAQ: CRON) Q4 2019 Earnings Conference Call Mar. 30, 2020 Corporate Participants: Anna Shlimak -- Investor Relations Mike Gorenstein -- Chairman, President and Chief
Aphria’s impressive Q1 earnings send the cannabis stock soaring
Shares of Aphria Inc (NYSE: APHA) shot up 19% during pre-market hours on Tuesday after it reported better-than-expected first-quarter earnings, in turn, healing
Can Aphria pull off another blockbuster quarterly earnings next week?
When Aphria Inc (NYSE: APHA) last reported quarterly results on August 1, the stock rallied almost 41% driven by an increase in
Aurora Cannabis reiterates revenue outlook for Q4, FY19
Cannabis producer Aurora Cannabis (NYSE: ACB) reiterated its production and revenue guidance for the fourth quarter and fiscal 2019 after evaluation of
Major marijuana stocks experience downward pressure this week
There has been extreme volatility in the share prices of Canadian-based cannabis companies’ stocks from their day one after getting listed on
Tilray posts wider-than-expected Q4 loss
Tilray (TLRY) reported a wider loss in the fourth quarter due to higher operating costs and expenses. For surviving the rising competition
Aurora Cannabis Q2 Earnings: Will the shopping spree continue?
Marijuana giant Aurora Cannabis (ACB) is scheduled to report its Q2 earnings on Monday after the bell. Last month, the company scaled
Thailand legalizes medical use of cannabis, opens up a new region for pot stocks
After Uruguay and Canada, Thailand has now amended its drug law to legalize marijuana for medical purposes. However, unlike the other two
GW Pharma Q4 results fails to impress the street
GW Pharmaceuticals plc (Nasdaq: GWPH) stock was down about 4% in the extended hours of trading after the company missed analyst estimates
Cronos reports loss in 3Q despite strong revenue growth
Cannabis producer Cronos Group (CRON) revenues jumped 186% to CAD3.76 million for the third quarter 2018, aided by strong sales growth of
Earnings preview: Tilray stock might see big fluctuations post Q3 results
It can be safely said that cannabis is this year’s bitcoin – be it the debates surrounding its regulation or the immense
Marijuana stocks experience a euphoric rise
Amidst the ongoing tussle to make cannabis use legal, the recent M&A deals in this industry have attracted many large institutional investors